Smoking-related population-attributable fractions for cancer varied from 8.8 percent to 35.7 percent
TUESDAY, Jan. 26, 2021 (HealthDay News) — A considerable proportion of cancer deaths are attributable to cigarette smoking, with variation across regions, according to a study published online Jan. 26 in Cancer Causes & Control.
Farhad Islami, M.D., Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated smoking-related population-attributable fractions (PAFs) for cancer mortality in those ages 30 years and older in 2013 to 2017 in 152 metropolitan or micropolitan statistical areas (MMSAs). Cross-sectional data for cigarette smoking prevalence were obtained from the Behavioral Risk Factor Surveillance System, and cancer mortality data were obtained from the U.S. Cancer Statistics Database.
The researchers found that the smoking-related PAFs of cancer varied from 8.8 percent in Logan (Utah-Idaho) to 35.7 percent in Lexington-Fayette (Kentucky). The MMSAs with the highest PAFs were in Appalachia and the South region. Within regions or states, there was substantial variation observed in PAFs across MMSAs; for example, the PAF ranged from 24.2 to 33.7 percent in the Northeast.
“This information is important to inform and help evaluate state and local-level tobacco control policies such as state-, city-, or county-level tobacco taxes and smoke-free air laws; investments in tobacco prevention; and increasing access to smoking cessation resources,” Islami said in a statement.
Abstract/Full Text (subscription or payment may be required)
Obesity Linked to Early-Onset Cancer Risk in Young Adults
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Financial Incentives Boost Tobacco Abstinence in Underserved Adults
2016 to 2024 Saw Increase in Patients Using Medical Cannabis
ED Visits for Gambling Disorder Spike After Canada Liberalizes Online Gambling
Aerobic Training, Behavioral Interventions Both Clinically Improve Asthma Control
Social Media Warnings Could Discourage Use Among Teens, Young Adults